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The Pulmonary Extracellular Lining
by Gerwyn George* and Gary E. R. Hook*
The extracellular lining of the lungs is reviewed. The pulmonary extracellular lining is a complex
mixture ofphospholipids, proteins and carbohydrates which is absolutely essential for the maintenance of
normal pulmonary functions such as gas exchange. Without the lining the lungs would collapse.
Alterations in the pulmonary extracellular lining may underlie some disease conditions induced by toxic
agents, especially those which interfere with the formation of pulmonary surfactant. The extracellular
lining could be used to detect and monitor damage and disease caused by agents toxic to the lungs. The
lining contains many hydrolytic enzymes which may act to detoxify certain toxic agents such as those
which contain ester groups. The pulmonary extracellular lining could play a significant role mediating the
toxic action of inhaled agents as well as the removal of those agents from the lungs.
Introduction
The extracellular lining (EL) ofthe lungs covers the
epithelium of the terminal bronchioles and alveoli. The
EL is a complex mixture of biomolecules, primarily
lipids and proteins. As the EL is at least partly derived
from the lung epithelium, and these cells are often the
primary target of toxic agents, then qualitative and/or
quantitative differences in components of the EL may
be useful as indicators of changes in epithelial cell
numbers or functions as part of the response to
toxicants. In addition, changes in the EL may also give
an insight into the mode of action of toxic agents on
the lung, which is oftenunknown atthe molecular level.
The modern era of research into the EL began with
von Neergaard in 1929 (1). He demonstrated that
surface tension forces played an important role in
normal lung mechanics, and he postulated that a
lowered surface tension was present at the tissue-air
interface. However, no further significant studies were
made until the 1950s. In 1953 (2), Low showed for the
first time that the alveolar epithelium consisted of a
continuous layer of cells, and in 1954 Macklin (3)
observed that this epithelium was covered with a thin
film of fluid. Then, pioneering studies by Pattle (4,5)
proved that a substance, nowusually called (pulmonary)
surfactant, was present on the distal lungsurfaces, that
the surfactant was capable of lowering surface tension
to very low levels, and that the surfactant was
essentially a specific lung secretion. Other investiga-
tions, primarily by Clements and co-workers (6-9),
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proved that lowered surface tension was essential for
lung function; if the surface tension was too high then
the lung alveoli tended to collapse at low volumes, i.e.,
at end-expiration. Surfactant also lines the terminal
bronchioles, preventing them from collapse at low
volumes (10). The vital importance of surfactant was
evidencedbythefindingthatsurfactantwasfunctionally
deficient in newborn babies suffering from respiratory
distress syndrome (11-13), a disease primarily charac-
terized by diffuse atelectasis (lung collapse) in the
affected infants. During the early 1960s, it was realized
that surfactant was composed mainly of phospholipid
(14,15), the major phospholipid beingdipalmitoyl-phos-
phatidylcholine (16). Macklin in the early 1950s (3,17)
suggested the Type II alveolar cell as the source of
surfactant, but it was not until the 1970s that this was
established with certainty. It is now known that
surfactant is stored in Type II cell organelles called
lamellar bodies, which are subsequently secreted into
the aqueous subphase of the EL (18-22). Once in the
subphase the lamellar bodies disrupt, perhaps into a
structure called tubular myelin (23,24), and ultimately
a thin monomolecular layer of surfactant is formed at
the air-liquid interface. However, the site(s) of degra-
dation of surfactant is still unknown. The most likely
site was considered to be the alveolar macrophage (25),
but this suggestion has not been supported by experi-
mental evidence (26,27). It now seems that most
surfactantisabsorbedbycells(s) ofthelungparenchyma
(26,27). During the last 10 years, it has become
apparent that the EL contains many nonsurfactant-
associated proteins, most of which are plasma-derived
(28-30), and also some enzymes (31). In addition to the
workdescribedhere, manystudieshavebeenperformed
on aspects of surfactant metabolism and control but
these studies are outside the scope of this review.GEORGE AND HOOK
Histology of the Alveolus
The alveolar epithelium mainly consists of two types
of cells (32,33) (Fig. 1). The type I cell (membranous
pneumonocyte) is a squamous cell. In the central region
of the cell is the nucleus and a small number of
organelles, e.g., lysosomes, mitochondria. From this
central region arise extensive outpushings of the cell
which cover over 90% ofthe alveolar surface. The Type I
cell is considered to be metabolically inactive (32,33).
The type II cell (granular pneumonocyte) is meta-
bolicallyhighlyactive andisthe sourceofthepulmonary
surfactant. The cell is roughly cuboidal in shape, has
microvilli on the apical surface and contains lamellar
bodies (32,33). Although the two kinds of cell are
present in about equal numbers in the normal alveoli,
the vast surface area ofthe Type I cells mean that less
than 10% ofthe gas-exchanging surface is represented
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by Type II cells (32,33). Overlying the surface of both
cell types (but thicker over the Type II cells) is a tightly
bound carbohydrate-rich glycocalyx, consisting mainly
ofglycosaminoglycans (34-37). Thealveolarmacrophage
is also presentin the alveoli, but as afree-movingcell on
top ofthe epithelium. It has a defensive function in the
lung, attempting to remove particles, bacteria, etc.,
that are deposited in the alveoli (38,39).
The EL overlies the epithelium (Fig. 1). In 1959,
Chase (40)firstreportedthepresence ofanextracellular
layer on the alveolar surface but technical problems
with fixation of the layer prevented further progress
until the work of Gil and Weibel (41,42) and others (43,
44). It was found that the EL had two components: (1) a
hypo(epi) phase which contained lamellar bodies and
tubular myelin and which was thought to be mainly
aqueous in nature and (2) a surface film (41,42). The
hypophase tended to be deeper in the alveolar "niches"
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FIGURE 1. Extracellular liningofpulmonary alveoli ofthe rabbit. (A) Extracellularlining(EL) overlies a lype II (T2)andTlype I (T1) cell. The
Type II cell contains lamellar bodies (LB) that are secreted into the alveoli. Two secreted lamellar bodies (SLB) are shownadjacent to some
tubular myelin (TM). x25,000 .(B) The basic organization of the extracellular lining consists of the surface film (SF) and underlying
hypophase (HP). x 108,000.
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and also seemed to contain protein. The hypophase was
overlaid by the surface film, a thin osmiophilic layer
which presumably represented the surfactant mono-
molecular layer, consisting mainly, if not entirely, of
phospholipid (Fig. 1). The EL oftheterminalbronchioles
also apparently possesses amonolayer ofsurfactant (10,
45). The hypophase in the bronchioles may contain a
protein-rich secretion from the bronchiolar Clara cell
(46,47); however, nothing is known about the nature of
this secretion.
Lamellar Bodies
The lamellar bodies present in Type II cells were first
suggested to be the intracellular storage form of
surfactant by Macklin (3). Since that time, many
morphological and biochemical studies have confirmed
thissupposition (18-22,48-50). Lamellarbodies seemto
be modified lysosomes, since they contain acid hydro-
lases (20,51-53) and appear to originate from multi-
vesicular bodies (53,54). A mature intracellular lamellar
body has dimensions ofthe order of1 to 3 ,um. The body
contains a core which itself contains a small number of
vesicles (55). Surrounding the core are lamellae which
are "typical" trilaminar phospholipid bilayers. The
periodicity of the lamellae has been variously reported
to be 42 A (56,57) and 66 A (54,58). There is a thin
outer matrix, in continuity with the core (55), and
outside this matrix is the limiting membrane (55) which
is lost when the lamellar body fuses with the plasma
membrane duringexocytosis (22). Onceinthe subphase,
lamellar bodies apparently "unravel" to form tubular
myelin.
Tubular Myelin
Thbular myelin was first described in the alveoli of
lungsthat had beenexposed to avariety oftoxic agents,
e.g., silica (59), cortisone (60) and 02 (61). It was later
found that tubular myelin is a component ofthe normal
EL (62-64), albeit in much smaller amounts than in
lungs exposed to toxicants (61,65). In the normal lung
tubular myelin is often found in alveolar niches (29).
When sectioned transversely, tubular myelin appears as
a quadratic lattice composed of lipid bilayers. (If cut
longitudinally, it appears as a parallel array of lipid
bilayers.) The distance between two bilayers is of the
order of 400 A (29) to 590 A (66,67). Some tubular
myelin is seen in inclusion bodies of alveolar macro-
phages but the physiological significance of this is
unknown (68). Under the electron microscope, tubular
myelin membranes can be seen in continuity with
membranes of disrupted lamellar bodies (22). Also,
lamellar bodies can be converted to tubular myelin in
vitro (67). Freeze-etching studies indicate that lamellar
body membranes are "smooth" (69), while membranes
oftubularmyelin contain particles at approximately the
same periodicity as that of the tubular myelin lattice
(66,69,70). Thus, it is considered that protein(s) have
an important function in organizing the structure of
tubular myelin. The function of tubular myelin is
thought to be as a "reserve" form of surfactant, before
the surfactant monolayer disperses onto the air-liquid
interface.
Biochemical Composition and
Toxicology of EL Components
The various classes of biomolecules of the EL are
present in or on the hypophase; this is mainly aqueous
in nature and the pH has been estimated to be
approximately6.9 invivo, bydirectmeasurement with a
microelectrode (71). The hypophase also contains a
store of reducing equivalent in the form of reduced
ascorbic acid (72), which is present at a much higher
concentration than that found in serum or lung tissue
(73).
The most commonly used method of obtaining
constituents of the EL for study is bronchoalveolar
lavage, usually with a (buffered) saline or balanced salt
solution. Although this method is a technically easy and
"gentle" technique, it must be remembered that the
whole ofthe lung-surface is lavaged. Thus, components
ofthe EL may be contaminated with molecules derived
from the upper airways, i.e., trachea and bronchi.
Therefore, it is possible, particularly for compounds
present in small amounts, that these compounds may be
mistakenly assigned to the EL. Also lavage always
contains free cells (usually macrophages in a normal
animal), but these are easilyremoved by centrifugation.
Lipids
Both intracellular surfactant, i.e. lamellar bodies
(74-77) and extracellular surfactant (78-81) have a
similar chemical make-up in a variety of species (Table
1). Both are composed predominantly of lipid, usually
with a small amount of protein, and trace amounts of
carbohydrate (78). Over80% ofthe lipid is phospholipid,
the major one (60-80%) being phosphatidylcholine (74,
78, 80). A high proportion ofthe phosphatidylcholine is
dipalmitoylphosphatidylcholine (DPPC), an unusual
phospholipid in that it possesses two saturated fatty
acids. DPPC is undoubtedly mainly responsible for the
surface tension lowering abilities ofsurfactant (82). The
second most abundant phospholipid is phosphatidyl-
glycerol (83,84), which is normally present only in trace
amounts in cells (84). Phosphatidylglycerol is also
thought to be important in surfactant function by
changing the physical properties of DPPC (85). The
other phospholipids consist of small amounts of phos-
phatidylserine, phosphatidylinositol, phosphatidyleth-
anolamine and lysophosphatidylcholine (76,85,86). The
remainder of the total lipid is composed of cholesterol,
cholesterol ester, triglycerides and free fatty acid (74,
80,81). It is not known whether the minor lipid
components (excepting phosphatidylglycerol) play a
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Table 1. Lipid composition of lamellar bodies and the extracellular lining.
% of Totala
PC PG PS PI PE Sph Lyso PC Others Reference
Species
Lamellar bodies
Ratb 64.6 13.-d 6.4 7.7 (45)
Ratb 77.8 11.8 1.2 2.9 4.2 0.7 (75)
Rabbitb 86.0 5.0 0.4 4.2 3.5 0.5 0.7 (76)
Rabbitb 73.0 8.1 - 6.8 - (77)
Extracellular lining
Dogc 77.8 5.2 1.5 0.9 13.9 (80)
Sheepc 58.4 4.4 - 3.5 1.5 2.5 10.9 19.3 (78)
Oxc 70.6 1.8 2.8 3.1 1.3 0.2 20.2 (78)
Ratc 72.6 4.5 4.5 4.1 2.1 0.2 10.4 (78)
Ratb 82.1 7.8 4.ld 4.1 2.0 (79)
Rabbitc 83.4 2.5 1.6 1.1 2.0 9.0
a PC = phosphatidylcholine; PG = phosphatidylglycerol; PS = phosphatidylserine; PI = phosphatidylinositol; PE = phosphatidyl-
ethanolamine; Sph = sphingomyelin; Lyso PC = lysophosphatidylcholine.
b % total phospholipid.
% total lipid (includes free fatty acids, triglycerides, cholesterol, and cholesterol esters.
d pS + pj.
significant role in the function(s) of surfactant.
Changes in the amount of lipid in the EL as part of
the response to toxicants have been reported several
times. Increases in the amounts of lamellar bodies
and/or tubular myelin in the alveoli, as revealed by
histological observation have been described in lungs
exposed to 02 (61), silica (59), cortisone (60) and nickel
dust (87). In extreme cases, after administration of
drugs such as chlorphentermine (88), chlorcyclizine (89)
or chloroquine (89), a phospholipidosis develops, which
is characterized by the presence oflamellated inclusions
innon-Type II cells ofthe lung(e.g., Type I, endothelial
cells, fibroblast) as well as a buildup oflipid material in
the airspaces. Quantitative studies, involving chemical
assay oflipids in lunglavages orwhole lungtissue, have
alsorevealed large increases. Forexample, inhalation of
chrysotile asbestos leads to an 11-fold increase in
extracellular surfactant level (90) and intratracheal
instillation of quartz results in a 12-fold increase in
extracellular surfactant (91). Heppleston et al. (92)
reported that total lung lipid increased 22 times after
inhalation of quartz. Heppleston (92) termed this
condition a lipo-proteinosis and under the light micro
scope the alveoli are filled with an amorphous PAS
positive material (93). A disease histologically similar tc
silica-inducedlipo-proteinosis, calledpulmonaryalveolar
proteinosis (PAP), is known in man (94). Its cause is
unknown. Lung lavage fluid from patients with PAP
contains large amounts oflipid and protein. Much ofthe
lipid is in "particulate" form (95), consisting of disinte-
grating cells, cell debris, lamellar bodies and unusual
vesiclesandmyelinlike structures(95). Inlipo-proteinosis
(92), PAP (96) and the increase in surfactant caused by
chrysotile asbestos (97) there are no major changes in
the composition ofthe lipid in the lavage orlung tissue.
The increase in levels of lipid is apparently due to
enhanced synthesis versus normal degradation, as a
result of exposure to asbestos (97) and silica (98).
However, Ramirez-R and Harlan (99) postulated that
synthesis of lipid was normal and degradation was
decreased in PAP but this finding was questioned by
Heppleston et al. (98). The increase in lipid is also
probably related to Type II cell proliferationinthe lung.
Type II cells can divide to replace Type I cells that have
been irreversibly damaged by toxic agents, e.g., NO2
(100), apparently common lung response to epithelial
injury. However, Type II cell hyperplasia to replace
damaged Type I cells has only been definitively
demonstrated after exposure to oxidant gases.
Decreases in lung lavage surfactant levels have been
reported in animals exposed to radiation (101) or
suffering from pneumonitis (102), and lower levels seem
to be present in human smokers versus nonsmokers
(30,103). Also, cadmium given to pregnant rats re-
sulted in decreased phosphatidylcholine concentrations
in the lungs of the fetuses (104). Reasons for the
decrease were not apparent, but presumably Type II
cells were damaged.
There are obvious dangers to the lung if surfactant
levels are decreased, primarily, atelectasis may occur
(5,8). In addition, increased surface tension on the
alveolar surface leads to increased transudation offluid
and solutes (105) from the capillaries, which might
result in pulmonary edema (105). Finally, the ability of
the lung to defend itself against bacteria could be
affected since surfactant is thought to help macro-
phages phagocytose and destroy bacteria (106,107). On
the other hand, the significance of increased levels of
surfactant to the lung are unknown. It is possible that
the mechanical properties ofthe lung could be affected.
In the case of the dust-induced increases, clearance of
the deposited dust from the alveoli may be altered by
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the amount of surfactant present. Also the chemical
properties of the dust surface may be changed; surfac-
tant can reduce the hemolytic activity of chrysotile
asbestos in vitro (108), and this could affect the
interaction of the dust with cells and hence its patho-
genic effect. Much is still unknown about the effects of
increased lipid levels on the lung.
In recent years, much attention has been paid to the
possible role of metabolites of arachidonic acid (i.e.,
leukotrienes, thromboxanes and prostaglandins) in the
development of some lung diseases, e.g., immediate
hypersensitivity reactions. Many studies have shown
that these compounds can be produced by cells present
in the lung, e.g., macrophages, mast cells. However,
there is little direct evidence, as yet, for the presence of
these molecules in the extracellular lining, either in
health or disease.
Glycolipids
Sahu et al. (96) reported thatglycolipids, namely GM3
ganglioside and GL1 cerebroside, were present in rabbit
lung lamellar bodies and particulate matter from lavage
ofpatients with PAP Slomiany et al. (109,110) described
acidic (sulfated) and neutral glycosyldiacylglycerols in
rabbit lung lavage, but these molecules may be contam-
inants from bronchial mucus. In all cases (96,109,110),
glycolipids represented 3 to 4% (w/w) ofthe total lipid.
Apparently nothing is known about the function(s) of
these glycolipids in the EL or whetherthey are affected
by toxic agents.
Glycosaminoglycans
The only glycosaminoglyean that has been detected in
lung lavage is hyaluronic acid (HA), which comprises 2
to 3% ofthe total nonlipid material lavaged from human
asthmatics (111). The source ofthe HA is thought to be
the Type II pneumocyte (112). However, the lavage from
healthy rabbits contains little or no HA (113). Increases
in HA may be important in delayed hypersensitivity
reactions of the lung, and possible other diseases, as
HA has the ability to agglutinate alveolar macrophages
(113).
Proteins
The question of whether specific surfactant apopro-
teins exist has caused much argument. Clements and
King (114) reported that two apoproteins, approximate
molecular weights 35,000 and 11,000, are present in
surfactant from various species. Sawada and Kashi-
wamata(115) described anapoprotein (molecularweight
36,000) in bovine lung surfactant, and a phosphatidyl-
choline-binding protein has been found in rat lung
lavage (116). Two unusual hydroxyproline-containing
peptides (molecular weight 62,000 and 36,000) have
been reported in lung lavage from people with PAP
(117) and innormallunglavage and lamellarbodies from
rabbit (118). Lamellar bodies from pig lung, as well as
pig surfactant, contain a highly hydrophobic group of
proteins, molecular weights 11,000 to 16,000 (119).
However, little detailed work has been done on the
protein composition of lamellar bodies. On the other
hand, various groups of investigators (120-123) have
denied that surfactant apoproteins exist, and they
postulate that proteins present in surfactant are an
artifact of the isolation and preparation procedures.
There is no apparent need for such apoproteins as the
surface tension-lowering abilities of surfactant can be
accomplished by pure lipid mixtures (124). It has been
suggested by King and Macbeth (125) that the 34,000
mw apoprotein is necessary for fast adsorption of
surfactant from the alveolar subphase onto the air-lipid
interface but Metcalfe et al. (126) reported in vitro
evidence against this supposition. Another possible
function forthe putative surfactant apoprotein is that of
organizing the tubular myelin, for which protein is
thought to be important (69,70,127).
Cell- and surfactant-free fractions of lung lavage
contain avariety ofproteins, most ofwhich areprobably
derived from plasma (28,30) (Table 2). The concen-
tration of plasma proteins in lavage effluents is similar
to their concentration in serum with the most abundant
being albumin, IgG, transferrin and a1-antitrypsin.
Albumin and IgG have also been histologically identified
inthe alveolar subphase ofthe EL (29,128). Presumably,
the other proteins are also present in this location. The
proteins are thought to be transferred from capillary to
alveolus and vice-versa by means ofpinocytosis through
Table 2. Plasma proteins in lavage effluents from the lungs of
healthy humansa
% of Total
Protein (mean + SEM)b
IgG 19.0 ± 1.7
IgA 10.2 ± 1.0
IgM 0.08 ± 0.04
IgD 0 0
IgE 0 ± 0
Il-Lipoprotein 0 ± 0
a2-Macroglobulin 0.34 ± 0.18
Fibrinogen 0 ± 0
C4 0.38 ± 0.03
C3 0.98 ± 0.09
Ceruloplasmin 0.30 ± 0.03
Plasminogen 0 ± 0
C-reactive protein 0 ± 0
Haptoglobin 0.96 ± 0.20
Transferrin 5.6 ± 0.3
Hemopexin 0.85 ± 0.09
Albumin 52.5 ± 2.5
Prealbumin 0.09 ± 0.01
a1-Antitrypsin 3.5 ± 0.3
Gc-globulin 0.24 ± 0.02
a2-HS-glycoprotein 0.65 ± 0.06
al-Acid glycoprotein 0.74 ± 0.12
12-Glycoprotein 1 0.16 ± 0.02
Total 96.0
a From Bell et al. (131).
b n = 23.
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the capillary endothelial cells and alveolar Type I cells
(29,128,129). It is probable that some protein crosses
the endothelium via intracellular clefts (130). There is
a size restriction on the transport of proteins from
plasma to alveolus -only those proteins with molecular
weights of approximately 150,000 or lower have un-
restricted transport (28,131). The only nonserum
protein present in normal lung lavage, excepting
"surfactant apoproteins," is secretory IgA-a special-
ized antibody which is specific to external secretions
(132). Probably, most IgA in the lung is present in the
upper airways (133), but small amounts may be associ-
ated with surfactant (134).
Presumably, IgG and IgA are present on the lung
surface to protect the lung from viruses, bacteria, etc.
As transferrin can have a bacteriostatic effect (135,
136), it also helps to protect the lung from bacterial
attack, and a1-antiprotease could prevent excess lung
damage due to protease release from inflammatory cells
(137). Whether the other serum proteins have specific
functions in the EL is unknown.
An increase in lung lavage protein is often seen in the
early phases of lung damage, e.g., as a result of
exposure to 02 (138), CdCl2 (139), paraquat (140) and
NO2 (141). However, this increase probably represents
intraalveolar edema-a relatively nonspecific indicator
of lung damage. Indeed, Alpert et al. (142) found that
passage of radiolabeled albumin from plasma to lung
surface was a sensitive index of edema after inhalation
ofozone (142). Longtermincreases (weeks tomonths) in
lung surface protein can be caused by radiation (101) or
intratracheal instillation of quartz (91). Perhaps the
most detailed studies have been performed on lavage
from patients with PAR This lavage contains large
amounts ofsolubleproteininaddition togreatquantities
of particulate material (95). In general, the protein
composition of patient lavage is very similar to that of
controls, butIgGand IgAconcentrations wereincreased,
and two apparently "new" proteins were found (28,143).
Thus it seems that in PAP the increase in protein occurs
without any loss of the selectivity and permeability of
the blood-air barrier.
The particulate material from PAP lavage also
contains large amounts of two glycoproteins, molecular
weight 62,000 and 32,000 (117, 144-148), althoughthese
proteins are proteolytic fragments of a larger 80,000
molecularweight protein (148). The 80,000 protein is, in
turn, a portion of a 250,000 molecular weight protein
(149). This 250,000 molecular weight protein is prob-
ably synthesized and secreted by Type II pneumocytes
(150). The parent protein, and its fragments, are
unusual inthat they possess short collagenlike sequences
in their peptide chains (144,146,148). However, it is
known that the proteins are not related to the comple-
ment component Clq.
A more subtle effect on lung surface protein has been
detected in smokers. Although smokers have near
normal amounts and composition of lavage protein
(131), the a1-antiprotease activity is reduced (151,152).
The protein is probably inactivated by oxidants in
cigarette smoke (153,154), which renders the protein
functionally inactive, while still retaining antigenic
reactivity in immunoassay techniques (151,152). This
has obvious implications for the development ofemphy-
sema (137).
Fibronectin is a glycoprotein, found in tissue and
plasma, which affects many interactions between cells
and the extracellular matrix. Small amounts of fibro-
nectin have been observed in lung lavage from normal
humans (155). Increased levels of the protein were
noted in lavage from patients suffering from interstitial
lung disease (156), possibly as a result of increased
synthesis by alveolar macrophages (155). The higher
levels of fibronectin in interstitial disease may play a
role in the pathogenesis of the syndrome, e.g., by
affecting the functions of fibroblasts. Alternatively,
fibronectin in the EL may be a "marker" for connective
tissue turnover in the lung (156).
As with changes in lipid levels, the significance of
increased levels ofprotein in the EL is not known. It is
possible that the increase represents edema, but it does
not seem likely that an animal could survive weeks or
months with edema without becoming severely ill or
dying. Perhaps the-most likely explanation is that
capillary permeability is increased as part of a chronic
low level inflammatory process, thus leading to an
increase in transport. of protein from plasma to lung
surface.
Enzymes
The only enzymes present in the normal EL of the
rabbit are acid hydrolases such as a-mannosidase,
1-hexosaminidase, acid phosphatase and an enzyme
with an alkaline pH optimum, alkaline phosphatase (31)
(Table 3). In addition Hayem et al. (157) reported the
presence of 1-hexosaminidase, oQ-mannosidase and
P-galactosidase in lung lavage from normal humans.
Nonspecific esterases have also been described in
association with purified surfactant (158). The enzymes
are found in the same compartment of the lung as the
surfactant, i.e., the EL, and are probably derived from
lamellar bodies (31) that appear to be modified lyso-
somes (20,51-53). The enzymes are thought to be
released into the EL when the lamellar bodies are
secreted onto the lung surface. There are differences
between the enzyme compositions of lamellar bodies
and lysosomes. Lamellar bodies contain very low
amounts of some acid hydrolases, e.g., arylsulfatase,
,B-glucuronidase (31) and alkaline phosphatase, an
enzyme not normally found in lysosomes. The alkaline
phosphatase found in the EL is apparently lung specific
(159). It is not known whether these various enzymes
have any functions within the EL itself.
Most interest in changes in lung surfactant enzymes
after exposure to toxic agents has been directed toward
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Table 3. Hydrolases of the pulmonary extracellular
lining of the rabbit.a
Activity, ,umolesubstrate % Total
hydrolyzed/30 min./total lung
extracellular lining activity
a-Mannosidase 24.3 ± 4.6 14.6
P-N-Acetylglucosaminidase 69.0 ± 5.5 8.3
1-Galactosidase 2.7 ± 0.5 3.3
Acid phosphatase 6.6 ± 2.5 1.3
Alkaline phosphatase 11.3 ± 4.0 2.8
a From Hook (31).
the possibility of using differences in enzyme levels as
markers oflung damage to aid in assessing the toxicity
ofvarious agents. A series ofstudies by Henderson and
co-workers have investigated the effects ofTriton X-100
(160), CdCl2 (139) and NO2 (141) on the lung. They
measured enzyme activities such as acid phosphatase,
alkalinephosphataseandlactatedehydrogenase, thelast
enzyme being present in very small amounts, ifat all, in
the normal EL (31). For all agents tested, there was a
dose-dependent increase in the amounts of all the
enzyme activities recovered by lavage (139, 141, 160).
Also, there seemed to be a correlation between the
extent of the increase and the extent of morphological
damage in the lung tissue which was observed some
time after the increase in the EL enzyme activities
(139, 141). Similar results, measuring lactate dehydro-
genase activity only, were reported by Roth (140) for
bromobenzene, paraquat and other compounds and by
Moores et al. (161) for intratracheal instillation of
quartz. In the latter study (161), the increased levels of
lactate dehydrogenase activity correlated well with the
increased numbers of neutrophils on the lung surface,
indicating that the cells were the major source of the
enzyme, at least inthis experiment. Thus, it seems that
measurement ofenzymesinthe EL showsgreatpromise
as a short-term "screening" test for agents capable of
damaging the lung.
Other workers have looked for the presence of
enzymes, such as collagenase and elastase, inthe lavage
ofpatients suffering from various disorders, in the hope
of gaining an insight into the pathogenesis of the
disease as well as a possible means of diagnosing its
severity. There is active collagenase in the lavage of
people with idiopathic pulmonary fibrosis, although no
elastase is present (162). High levels of elastase have
been found in lavage from cases ofpneumoconiosis (163)
and patients suffering from adult respiratory distress
syndrome (164). The enzymes are probably derived
from activated alveolar macrophages (165,166) or
neutrophils (167). The presence of the enzymes could
indicate continuing connective tissue breakdown in the
lung interstitium (162). If the restructuring process
were to be altered in some way then this may lead to
fibrosis of the connective tissue (162).
Immunology of the EL
The "immune system" ofthe EL is simpler than that
of serum. Only two classes of antibody, A and G, are
normally present (28,30,131). Most of the IgA is
present as dimeric IgA (133) and is thought to be mainly
presentin theupperairways -the deep airspaces ofthe
lung being protected by IgG (133). Some complement
components, viz., C3, C4, and C6, have also been
detected in lung lavage (30,131). The EL has higher
concentrations of IgG and IgA compared to serum,
probably as the result of local synthesis of antibody.
Both IgA and IgG can by synthesized by a lung mince
(168) and Kaltreider and Salmon (169) reported that
B-lymphocyte plasma cells isolated by lavage could
synthesize and secrete IgG. Thus the lung can produce
antibody both in the interstitium and the airways (133,
169). T-lymphocytes are also present onthe lungsurface
and can be obtained by lavage. These cells are less
responsivethan serumT-lymphocytes to certain stimuli.
Part ofthe inhibition is due tothe effect ofsurfactant on
the cells (170,171), althoughthemechanismisunknown.
Thus, the immune system ofthe lung may be function-
ally different from that ofthe rest ofthe body. The lung
is known to be at least partly independent of the
systemic immune system (172).
Elevated levels ofIgG and/or IgA have been observed
in the lung lavage from patients suffering a variety of
diseases. IgGincreases inidiopathicpulmonaryfibrosis,
chronic hypersensitivity pneumonitis and sarcoidosis
(173,174). Both IgAand IgGareincreasedinpulmonary
alveolar proteinosis and in pigeon breeder's disease
(28,175). In at least one disease, sarcoidosis, the
increasedlevels ofantibodywerecorrelated toincreased
numbers of IgG secretory cells in patient lung lavage.
Also, the clinical severity of the disease seemed to be
related to the number of IgG secreting cells. This
provides evidence of the direct involvement of EL
proteininthisdisease. However, whetherthisconclusion
applies to otherlungdiseases, orwhetherthe increased
amounts ofIgA and IgG in other syndromes is a result,
rather than the cause of the disease, is unknown.
The EL in Pulmonary Toxicology
We have briefly reviewed and summarized our know-
ledge of the EL. The EL is a highly complex system
with apparent functions which include and lie beyond its
major accepted role as stabilizer ofthe alveoli and distal
airways. Considering the critical importance ofthe EL
to the lungs and mounting evidence, the EL must be
identified as a target for toxic agents. Many questions
have yet to be answered concerning the interactions
between the EL and toxic agents: how do toxic agents
produce alterations in the EL, how may the system
changebothinqualityand/orquantitybeforepulmonary
functions are seriously compromised, does a threshold
exist beyond which pulmonary collapse is inevitable,
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which aspects ofthe EL are particularly susceptible to
toxic agents, and how and to what degree may the
system protect itself? A great deal ofresearch remains
to be done before the role of the EL in pulmonary
toxicology can be fully defined.
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